医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Anemia classified by red-cell size and hemoglobin content. Microcytic hypochromic anemia means small RBC volume with RBC hemoglobin below normal.
血液科Hypochromic microcytic anemia (D50.800x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other iron-deficiency anemia (D50.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Kelly-Paterson syndrome (D50.100x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Plummer-Vinson syndrome (D50.100x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Chronic hemorrhagic anemia (D50.001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Iron-deficiency anemia secondary to (chronic) blood loss (D50.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduct
Posttransplant lymphoproliferative disorders (PTLD) are among the most serious complications after organ/cell transplantation, recognized over 30 years ago; questions raised then remain incompletely answered.
血液科Castleman disease (CD) is one of the idiopathic reactive lymphadenopathies, relatively rare clinically, characterized by marked deep/superficial lymphadenopathy; some cases have systemic symptoms and/or multi-system damage. Most cases do well after surgic
血液科Essential thrombocythemia is a myeloproliferative disease characterized by bleeding tendency and thrombosis; defined as peripheral platelet count above the normal upper limit 400x10^9/L with abnormal function and excessive marrow megakaryocyte proliferati
血液科Primary myelofibrosis (PMF) is a chronic myeloproliferative disease caused by unknown abnormal hematopoietic stem cells; marked bone-marrow fibrous-tissue hyperplasia and extramedullary hematopoiesis are the pathologic basis of PMF.
血液科Myelodysplastic syndrome (MDS) is a heterogeneous clonal disorder arising from myeloid committed/pluripotent hematopoietic stem cells; basic lesion is clonal hematopoietic stem/progenitor dysplasia causing ineffective hematopoiesis and increased malignant
血液科Polycythemia vera (PV) is a clonal chronic myeloproliferative disorder mainly characterized by erythrocytosis with leukocytosis/thrombocytosis, absolute increase in total blood volume, blood hyperviscosity; clinical picture: red-purple skin, dizziness, he
血液科Blood cancer = clonal malignant hematopoietic-stem-cell disease; leukemic cells lose differentiation/maturation capacity; accumulate in marrow/hematopoietic tissue and infiltrate organs; suppress normal hematopoiesis → anemia/bleeding/infection. Treatable
血液科Malignant white-cell neoplasm; immature WBCs diffusely infiltrate marrow/blood and widely infiltrate liver/spleen/nodes/skin. Specific lesions: macules/papules/plaques/nodules/purpura. Diagnosis by cell type + infiltration pattern + clinic/hematology; cyt
血液科Rare leukemia diagnosed from birth to 8 weeks. Unknown cause; genetic/constitutional/intrauterine factors. Associated with congenital anomalies (trisomy 21, Turner).
血液科Malignant transformation of hematopoietic stem/progenitor cells; loss of proliferation/differentiation/maturation control; uncontrolled proliferation replaces marrow and infiltrates organs. Malignant hematopoietic tumor (blood cancer). Diagnosis by marrow
血液科Extramedullary leukemic-cell infiltration of leptomeninges/adjacent neural tissue; common complication; prognostic impact. Can occur at any stage.
血液科Malignant mast-cell clonal disease; may arise from systemic mastocytosis (type II/III) or de novo. Two feature groups: infiltration (hepatosplenomegaly/nodes/bone lesions/urticaria pigmentosa) + mediator release (histamine/heparin/kinins/prostaglandins).
血液科Specific skin lesions: purple to red-brown papules/nodules/plaques. AMOL may have bullous lesions; rapid course; spontaneous regression. Leukemic gingival hyperplasia (60%). Congenital monocytic leukemia rare.
血液科
|
